Evidence map›Paper›PMID 19359066›Full record

ArticleAtencion primaria2009

[Improved effectiveness in the management of cardiovascular risk among type 2 diabetic patients in primary health care].

Antonio Hormigo Pozo, María Angeles Viciana López, Leonor Gómez Jiménez, María Dolores Gallego Parrilla, Javier Orellana Lozano, José Miguel Morales Asencio

Open access · greenAbstract readEnglish AbstractMulticenter Study
In one paragraph

Article in Atencion primaria, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Risk scoring for the primary prevention of cardiovascular disease.The Cochrane database of systematic reviews · 2017
    Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Antonio Hormigo PozoCentro de Salud Puerta Blanca, Distrito Sanitario Málaga, Málaga, España. cpuertablanca@hotmail.com
María Angeles Viciana López
Leonor Gómez Jiménez
María Dolores Gallego Parrilla
Javier Orellana Lozano
José Miguel Morales Asencio
Universidad de Málaga · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo determine the impact of the implementation of a guidelines in the assessment of cardiovascular risk in high-risk patients (type 2 diabetes) in health centres, and to analyse the appropriateness of antihypertensive and antiplatelet treatment in diabetic patients.

designQuasi-experimental, non-randomised, prospective study with concurrent control group. PLACEMENT: Two health centres in Málaga.

participantsGeneral practitioners of the two centres.

interventionsThe guideline was implemented through a multifaceted intervention in family physicians in the experimental centre. MAIN OUTCOMES: Rate of cardiovascular risk assessment in high risk population. Secondary: appropriateness of antihypertensive and antiplatelet treatment.

resultsLarge differences were detected in the cardiovascular risk assessment, improving in the experimental group (74.36% vs. 7.63%; RR = 9.74; 95% CI, 5.15-18.43; P = .0001). Similarly, the antiplatelet use was more in line with the guidelines recommendations in the intervention group (51.28% vs. 36.44%; RR = 1.407; 95% CI, 1.04-1.89; P = .026), and in antihypertensive drugs, although with no statistical significance (80% vs. 66.27%; RR = 1.207; 95% CI, 0.99-1.46).

conclusionsA multifaceted intervention for the implementation of a guideline for the management of high risk cardiovascular patients, improves the adherence to effective interventions by family physicians.

Indexed as

Primary Health CareAntihypertensive AgentsCardiovascular DiseasesDiabetes Mellitus, Type 2FemaleGuideline AdherenceHumansMaleMiddle AgedPlatelet Aggregation InhibitorsProspective StudiesRisk AssessmentRisk FactorsAntihypertensive AgentsPlatelet Aggregation Inhibitors

Identifiers

PMID19359066
PMCPMC7021938
OpenAlexW1990585446

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.